MarginsXMarginsX
Home › Markets › CYDY

CytoDyn Inc. (CYDY)

CYDY is quoted over the counter, not listed on an exchange. CytoDyn Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.2502
+0.1% on the day
1-year return
-7.3%
Market cap
$367.7M
Small cap. From the Nov 16, 2026 close × 1.47B shares (10-Q cover page, Sep 30, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to August 31, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerCYDY, quoted over the counter
SEC CIK0001175680
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressVancouver, WA
Incorporated inDE

Warning signs

Cash runway
8.7 months
$16.4M cash at August 31, 2026
Share count, 1 year
+16.7%
2025-09-30 to 2026-09-30 · +57.8% over 3 years
Going-concern doubt
Yes
10-Q filed October 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors, among others, including the various matters discussed in Note 10, Commitments and Contingencies , raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-10-14
Cash and burn$16.4M cash; operating cash flow -$5.6M a quarter.Report 2026-08-31
Shares outstanding1,469,518,000 (2026-09-30); 1,259,753,000 a year earlier; 931,151,762 three years earlier.Cover page 2026-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-09-25
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., Hartford, Connecticut, United States; changed auditors 1 time in 24 months8-K 4.01 2025-05-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-08-31
Not filed-$19.9M-$7.7M$16.4M$35.8MNeeds four quarters10-Q 2026-10-14
Q4 2026
2026-05-31
Not filed-$9.9M-$4.9M$11.9M$38.3MNeeds four quarters10-K 2026-08-31
Q3 2026
2026-02-28
Not filed-$4.7M-$5.5M$15.7M$40.5MNeeds four quarters10-Q 2026-04-08
Q2 2026
2025-11-30
Not filed-$22.6M-$4.3M$5.0M$42.2MNeeds four quarters10-Q 2026-04-08
Q1 2026
2025-08-31
Not filed-$5.5M-$2.5M$9.3M$43.8MNeeds four quarters10-Q 2026-10-14
Q4 2025
2025-05-31
Not filed-$6.0M-$5.7M$11.9M$45.4MNeeds four quarters10-K 2026-08-31
Q3 2025
2025-02-28
Not filed-$4.8M-$5.0M$16.4M$45.8MNeeds four quarters10-Q 2026-04-08
Q2 2025
2024-11-30
Not filed-$4.8M-$3.6M$21.3M$46.1MNeeds four quarters10-Q 2026-04-08

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-10-07
Latest annual report10-K2026-08-31
Latest quarterly / interim10-Q2026-10-14
Latest current report8-K2026-10-19
Latest proxyDEFA14A2026-10-19

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier